In this March 16, 2020, file photo, a subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle.
Ted S. Warren | AP
The National Academies of Sciences, Engineering, and Medicine on Tuesday released a draft proposal for distributing a coronavirus vaccine in the U.S. if and when one is approved for public use.
The vaccine would be distributed in four phases, with health-care workers and vulnerable Americans, like the elderly and those with underlying health conditions, getting it first, according to the group. They devised the proposed guidelines at the request of the National Institutes of Health and Centers for Disease Control and Prevention.
This is a developing story. Please check back for updates.
